$141.74
+6.50 (+4.81%)
MOH News5 articles
UnitedHealth Shares Edge Higher Amid Medicare Rate Scrutiny and Broader Market Volatility
UnitedHealth Group stock rose slightly as investors assessed a modest proposed Medicare Advantage payment increase for 2027. The healthcare giant continues to navigate pressure following a significant revenue warning earlier this year.
UnitedHealth Rallies 3% to Close Volatile Week; Medicare Advantage Outlook in Focus
UnitedHealth shares gained 3% Friday to $276.65, stabilizing after a turbulent period for managed-care stocks. Investors now await earnings from CVS Health and Humana next week for critical updates on Medicare Advantage trends.
Hims Halts Compounded GLP-1 Pill as FDA Cracks Down, Molina Plunges on Profit Warning
Hims & Hers discontinues its $49 compounded semaglutide offering following FDA enforcement signals, sending shares down 16%. Molina Healthcare forecasts 2026 profit far below expectations, triggering a 28% stock drop.
UnitedHealth Rebounds 3% as Managed Care Sector Weighs Diverging Cost Outlooks
UnitedHealth shares rose 3% to $276.65 Friday, recovering after Molina Healthcare's weak 2026 forecast pressured the sector. Investors now await Humana's results and a key Medicare Advantage rate decision.
Healthcare Sector Sees Divergence: Molina Plunges on Outlook, XLV Gains Amid Regulatory Warnings
Molina Healthcare plummeted 25.5% after slashing its 2026 profit forecast and announcing a Medicare Part D exit, while the Health Care Select Sector SPDR Fund (XLV) rose 1.8%. Regulatory warnings on compounded obesity drugs added pressure to the sector.